Le Lézard
Classified in: Health, Business
Subject: CXP

Siemens Healthineers Announces the Expansion of Ottawa Manufacturing Facility


OAKVILLE, ON, Oct. 11, 2018 /CNW/ - Siemens Healthineers has announced that its Ottawa, Ontario manufacturing facility that manufactures the epoc® blood analysis system will be expanded by 5000 square feet to support new manufacturing lines and accommodate growth of the healthcare business worldwide and in Canada.

Siemens Healthineers (CNW Group/Siemens Healthineers)

The epoc system is a handheld, wireless solution that enables comprehensive blood analysis testing at the patient's side on a single room-temperature test card, with results in less than a minute.

"This investment is a critical step toward enabling the growth of our medical technology business in Canada and Ontario by ensuring we have the manufacturing capacity in place to support continued development," said Eric LaFleche, General Manager of Siemens Healthineers in Canada. "We are proud that the skills and experience of staff are recognized, and Canada continues to be known for its technology, skills, and favourable innovative business environment."

The 5000 square-foot expansion is expected to be complete by June 2021, and will complement the company's other point-of-care operations in the United States, United Kingdom, and India.

The point-of-care testing portfolio from Siemens Healthineers includes several solutions designed to provide immediate, convenient, and easy-to-use diagnostic testing. From the emergency department to the physician's office, clinical management decisions can be made immediately and result in improved patient safety, clinical outcomes, and overall patient satisfaction. The Ottawa facility is focused on the manufacture of the epoc blood analysis system, which provides critical caregivers with real-time, laboratory quality test results at the patient's bedside.

The epoc blood analysis system can be used for a wide range of tests including: blood gas, which measures the amount of oxygen and carbon dioxide in the blood that can indicate the presence of certain medical conditions such as kidney disease, heart failure, diabetes, hemorrhage, chemical poisoning, a drug overdose, or shock, among others; electrolytes and metabolytes, which indicate kidney health, blood sugar levels, and levels of electrolytes such as potassium and sodium; lactate that tests for sepsis; creatinine, which indicates kidney function; and blood urea nitrogen that reveals information about how well the kidneys and liver are functioning.

More information on the Siemens Healthineers epoc blood analysis system is available online.

Follow us on Twitter at: https://twitter.com/SiemensHealth

Siemens Healthineers enables healthcare providers worldwide to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving patient experience and digitalizing healthcare. A leader in medical technology, Siemens Healthineers is constantly innovating its portfolio of products and services in its core areas of diagnostic and therapeutic imaging and in laboratory diagnostics and molecular medicine. Siemens Healthineers is also actively developing its digital health services and enterprise services. In fiscal 2017, which ended on September 30, 2017, Siemens Healthineers generated revenue of ?13.7 billion and adjusted profit of ?2.5 billion and has about 48,000 employees worldwide. Further information is available at www.siemens-healthineers.com.

SOURCE Siemens Healthineers


These press releases may also interest you

at 08:15
Code, an innovator in healthcare automation and mobile technology, was honored at the 2019 Utah Genius Awards for the number of patents issued during the 2018 calendar year. It is the third straight year Code has been recognized for key contributions...

at 08:00
Dr. Brock Pumphrey of Midtown Center for Advanced Periodontics, Cosmetic & Implant Dentistry is now certified in the LANAP and LAPIP protocols. Dr. Pumphrey is on the leading edge of periodontics, treating patients with a minimally invasive laser...

at 08:00
"Mother. Sister. Friend. Together we can save the lives of the women we love" ? inspiring words from the Go Red for Women campaign from the American Heart Association. Cardiovascular diseases, many of them preventable with the right education and...

at 07:00
Invesque Inc. (the "Company") will release its fiscal 2019 first quarter results on Tuesday, May 14, 2019 after markets close. Management of the Company will hold a conference call at 10:00 a.m. ET on Wednesday, May 15, 2019 to review the financial...

at 07:00
Dozens of the nation's most iconic national landmarks will "Light Up Orange" to celebrate the 100th Anniversary of Easterseals, which takes place on Monday, April 22, 2019. Easterseals, the nation's largest nonprofit...

at 07:00
Patients prescribed opioid pain medications whose doses varied over time were 3 times more likely to experience an overdose than patients prescribed stable opioid doses, according to an observational study from Kaiser Permanente published today in...



News published on 11 october 2018 at 11:50 and distributed by: